Oxford Biomedica PLC
17 April 2001
OXFORD BIOMEDICA PLC
Completion of Fund Raising
The London Stock Exchange has announced today that all of
the ordinary share capital of Oxford BioMedica plc has
been admitted to the Official List and has been admitted
to trading on the London Stock Exchange, thereby
satisfying the final outstanding condition of the Placing
and the Open Offer, announced by the Board of the Company
on 12 March 2001. The Placing and the Open Offer raised
approximately £30 million, net of expenses.
In addition to this, Beeson Gregory Limited has raised
approximately £2.6 million, before expenses, through the
placing of Offer Shares, not taken up by Qualifying
Shareholders, with institutional investors.
*A Private Investor is a recipient of the information who meets all of the conditions set out below, the recipient:
Obtains access to the information in a personal capacity;
Is not required to be regulated or supervised by a body concerned with the regulation or supervision of investment or financial services;
Is not currently registered or qualified as a professional securities trader or investment adviser with any national or state exchange, regulatory authority, professional association or recognised professional body;
Does not currently act in any capacity as an investment adviser, whether or not they have at some time been qualified to do so;
Uses the information solely in relation to the management of their personal funds and not as a trader to the public or for the investment of corporate funds;
Does not distribute, republish or otherwise provide any information or derived works to any third party in any manner or use or process information or derived works for any commercial purposes.
Please note, this site uses cookies. Some of the cookies are essential for parts of the site to operate and have already been set. You may delete and block all cookies from this site, but if you do, parts of the site may not work. To find out more about the cookies used on Investegate and how you can manage them, see our Privacy and Cookie Policy
To continue using Investegate, please confirm that you are a private investor as well as agreeing to our Privacy and Cookie Policy & Terms.